Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 61
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Tidsskr Nor Laegeforen ; 143(16)2023 11 07.
Artículo en Noruego | MEDLINE | ID: mdl-37938009

RESUMEN

BACKGROUND: Neurological disorders can present with a vast array of visual disturbances. The constellation of symptoms and findings in this patient prompted workup for unusual causes of both stroke and neurodegenerative disorder. CASE PRESENTATION: A woman in her sixties presented with visual disturbances, followed by weakness in her right arm and aphasia three days later. Her close acquaintances had suspected progressive cognitive decline during the previous year. CT and MRI showed an occluded left posterior cerebral artery with a subacute occipito-temporal infarction. The finding of extensive white matter lesions and segmental arterial vasoconstriction necessitated further workup of vasculitis and hereditary small vessel disease, which were ruled out. The stroke aetiology was considered to be atherosclerotic intracranial large vessel disease. FDG-PET scan revealed decreased metabolism in the left hemisphere, and cerebrospinal biomarkers had slightly decreased beta-amyloid. The findings were suggestive of early Alzheimer's disease or primary progressive aphasia, but currently inconclusive. INTERPRETATION: Based on clinical-anatomical correlation, the patient's visual disturbances, in this case right hemianopsia and object agnosia, were solely related to the stroke and not to a neurodegenerative disorder. Knowledge and interpretation of visual agnosias can in many cases be clinically valuable.


Asunto(s)
Agnosia , Enfermedades Neurodegenerativas , Accidente Cerebrovascular , Femenino , Humanos , Agnosia/diagnóstico , Agnosia/etiología , Imagen por Resonancia Magnética , Enfermedades Neurodegenerativas/complicaciones , Tomografía de Emisión de Positrones , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/diagnóstico por imagen , Trastornos de la Visión , Anciano
2.
J Neuroophthalmol ; 41(4): e516-e522, 2021 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-33252889

RESUMEN

BACKGROUND: A possible benefit of optical coherence tomography (OCT) in the approach to tumors involving the optic chiasm may be the ability to foresee visual deterioration. This study investigated the value of OCT in watchful waiting for compressive optic neuropathy as the primary management of suprasellar masses. METHODS: The research was conducted as a 2-year observational study of a patient cohort with conservatively managed mass lesions involving the optic chiasm on MRI. Threshold perimetry and macular OCT were performed at baseline and each follow-up examination. Univariate Cox regression was used to determine the effect of baseline and longitudinal covariates upon development of visual field (VF) loss compatible with chiasmal dysfunction. RESULTS: Nineteen eyes of 19 patients were included. The optic chiasm-tumor relationship on baseline MRI was abutment in 6 cases and compression in 13 cases. Seven eyes developed VF loss. None of the baseline covariates were predictors of VF loss. The longitudinal decrease in mean macular ganglion cell complex (mGCC) thickness on OCT was 2.5 µm/yr for eyes that developed VF loss and 0.2 µm/yr for eyes that did not develop VF loss (P = 0.02). The hazard ratio for VF loss per 1-µm/yr decrease in mGCC thickness was 1.30 (95% confidence interval [CI] 1.04-1.62; P = 0.02) for the inferior nasal quadrant and 1.45 (95% CI 1.02-2.07; P = 0.04) for the inferior temporal quadrant. CONCLUSIONS: OCT offers a valuable complement to perimetry in monitoring for compressive optic neuropathy. Longitudinal mGCC thinning can anticipate VF loss.


Asunto(s)
Tomografía de Coherencia Óptica , Espera Vigilante , Humanos , Células Ganglionares de la Retina/patología , Tomografía de Coherencia Óptica/métodos , Pruebas del Campo Visual , Campos Visuales
3.
Tidsskr Nor Laegeforen ; 141(5)2021 03 23.
Artículo en Noruego | MEDLINE | ID: mdl-33754676

RESUMEN

BACKGROUND: The aetiology of transient monocular vision loss is not necessarily thromboembolic, and careful history-taking is crucial in making the correct diagnosis. CASE PRESENTATION: A previously healthy woman in her thirties was referred to our outpatient stroke clinic on suspicion of recurring amaurosis fugax in her right eye. The ophthalmic and neurologic examinations were normal. A review of the medical history revealed that her symptoms occurred in connection with using her smartphone in bed, typically while lying on her left side with the left eye covered by the pillow. When standing up from the bed again with the lights turned off in the bedroom, she noticed vision loss in her right eye. INTERPRETATION: We concluded that the patient had experienced transient smartphone blindness. This phenomenon can occur when monocularly using a smartphone under scotopic lighting conditions; only the occluded eye adapts to darkness, and the other eye is perceived to be blind if looking away from the bright smartphone screen.


Asunto(s)
Ceguera , Teléfono Inteligente , Amaurosis Fugax/diagnóstico , Ceguera/diagnóstico , Ceguera/etiología , Diagnóstico Diferencial , Femenino , Humanos , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/etiología
4.
Tidsskr Nor Laegeforen ; 141(9)2021 06 08.
Artículo en Inglés, Noruego | MEDLINE | ID: mdl-34107654

RESUMEN

BACKGROUND: Toxoplasmosis is a relatively common cause of infectious papillitis and neuroretinitis, which may affect both immunocompetent and immunodeficient patients. CASE PRESENTATION: A previously healthy woman in her mid-forties presented with subacute onset of unilateral blurred vision and retrobulbar pain exacerbated by eye movements. Ophthalmological assessment revealed decimal best-corrected visual acuity of 0.75, an ipsilateral swollen disc and a peripapillary infiltrate. Serology indicated acute infection with Toxoplasma gondii. Cerebral MRI showed a periventricular lesion, and oligoclonal bands were detected in the cerebrospinal fluid. INTERPRETATION: This case illustrates that even when symptoms, MRI and cerebrospinal fluid findings suggest demyelinating disease, differential diagnoses must be considered in order to mitigate the negative therapeutic and prognostic consequences of a misdiagnosis.


Asunto(s)
Movimientos Oculares , Papiledema , Femenino , Humanos , Dolor , Trastornos de la Visión/diagnóstico
5.
Graefes Arch Clin Exp Ophthalmol ; 258(3): 503-511, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31889214

RESUMEN

PURPOSE: To analyse current off-label use of bevacizumab for wet age-related macular degeneration (AMD) in Europe. METHODS: The study was conducted as a combined survey and literature review. It included the 22 most populous countries in Europe. In each country, ophthalmologists with particular knowledge about off-label treatment responded to a questionnaire. RESULTS: Answers were obtained from twenty European countries. The off-label use of bevacizumab for wet AMD greatly differed between nations; the bevacizumab proportion varied from non-existent (0%) to very high (97%). There were also large disparities within single countries (e.g. 0-80%), which were attributable to differences in regional decision-making. Both governmental institutions and national ophthalmological societies expressed highly diverging opinions on the use of off-label treatment. Intravitreal administration of bevacizumab had been a matter of legal dispute in several countries. The question about responsibility for off-label therapy mainly remained unanswered. CONCLUSIONS: There was a highly varying utilization of bevacizumab between European countries. Despite an intention of a consistent approach to medical regulations, Europe has not yet reached a professional or political consensus on the ophthalmic off-label use of bevacizumab.


Asunto(s)
Bevacizumab/administración & dosificación , Uso Fuera de lo Indicado/legislación & jurisprudencia , Ranibizumab/administración & dosificación , Degeneración Macular Húmeda/tratamiento farmacológico , Inhibidores de la Angiogénesis/administración & dosificación , Europa (Continente)/epidemiología , Humanos , Incidencia , Inyecciones Intravítreas , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Agudeza Visual , Degeneración Macular Húmeda/epidemiología
6.
J Neuroophthalmol ; 38(1): 54-56, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29016409

RESUMEN

A 72-year-old woman experienced anterior ischemic optic neuropathy in her left eye. The funduscopic and fluorescein angiographic findings were strongly suggestive of giant cell arteritis. Temporal artery biopsy revealed extensive calcification in the vessel wall consistent with calciphylaxis. This unusual disorder should be considered in the differential diagnosis of anterior ischemic optic neuropathy, particularly the arteritic form.


Asunto(s)
Calcifilaxia/complicaciones , Neuropatía Óptica Isquémica/etiología , Anciano , Biopsia , Calcifilaxia/diagnóstico , Femenino , Angiografía con Fluoresceína , Humanos , Neuropatía Óptica Isquémica/diagnóstico , Arterias Temporales/patología , Agudeza Visual/fisiología , Campos Visuales/fisiología
7.
Tidsskr Nor Laegeforen ; 138(12)2018 08 21.
Artículo en Noruego | MEDLINE | ID: mdl-30132618

RESUMEN

BACKGROUND: The diagnosis of acute optic neuropathy is made clinically. In young patients demyelinating optic neuritis is the most common cause. However, other autoimmune diseases, infections and other non-inflammatory conditions may also cause inflammation. Careful clinical workup is necessary to establish the correct diagnosis and treatment. We describe the clinical approach to a case of acute optic neuropathy with several atypical features. The same case was published in the Journal of Neuro-Ophthalmology. CASE PRESENTATION: A male teenager developed acute and painless bilateral visual loss. Fundoscopy revealed optic disc hypaeremia with telangiectasia. Magnetic resonance imaging demonstrated contrast enhancement of the optic nerves and chiasm without evidence of demyelinating disease. There was no visual improvement after methylprednisolone treatment. Genetic analysis for the 3 common Leber hereditary optic neuropathy (LHON) mutations was negative. However, idebenone treatment was followed by a marked improvement in visual function. Whole mitochondrial genome sequencing eventually detected a rare LHON mutation. INTERPRETATION: There are many different causes of acute optic neuropathy. Making the correct diagnosis is important, as clinical management differs. Idebenone is now a treatment option for LHON. Whole mitochondrial genome sequencing is sometimes necessary to confirm the diagnosis.


Asunto(s)
Atrofia Óptica Hereditaria de Leber , Trastornos de la Visión/etiología , Adolescente , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Humanos , Masculino , Oftalmoscopía , Atrofia Óptica Hereditaria de Leber/complicaciones , Atrofia Óptica Hereditaria de Leber/diagnóstico , Atrofia Óptica Hereditaria de Leber/tratamiento farmacológico , Atrofia Óptica Hereditaria de Leber/genética , Mutación Puntual , Resultado del Tratamiento , Ubiquinona/administración & dosificación , Ubiquinona/análogos & derivados , Ubiquinona/uso terapéutico , Pruebas del Campo Visual
12.
Tidsskr Nor Laegeforen ; 141(5)2021 03 23.
Artículo en Inglés, Noruego | MEDLINE | ID: mdl-33754679

RESUMEN

The story of research on multiple sclerosis in Norway starts in 1945 at a private Catholic hospital in the town of Hamar, where the ophthalmologist Marius Haarr was treating patients with retinal periphlebitis and neurological symptoms. He completed his doctoral degree while raising two young children as a widowed father.


Asunto(s)
Esclerosis Múltiple , Humanos , Esclerosis Múltiple/diagnóstico , Esclerosis Múltiple/tratamiento farmacológico , Noruega/epidemiología
17.
Sci Rep ; 14(1): 15618, 2024 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-38971860

RESUMEN

To compare two screening strategies for diabetic retinopathy (DR), and to determine the health-economic impact of including optical coherence tomography (OCT) in a regular DR screening. This cross-sectional study included a cohort of patients (≥ 18 years) with type 1 or 2 diabetes mellitus (T1D or T2D) from a pilot DR screening program at Oslo University Hospital, Norway. A combined screening strategy where OCT was performed in addition to fundus photography for all patients, was conducted on this cohort and compared to our existing sequential screening strategy. In the sequential screening strategy, OCT was performed on a separate day only if fundus photography indicated diabetic macular edema (DME). The presence of diabetic maculopathy on fundus photography and DME on OCT was determined by two medical retina specialists. Based on the prevalence rate of diabetic maculopathy and DME from the pilot, we determined the health-economic impact of the two screening strategies. The study included 180 eyes of 90 patients. Twenty-seven eyes of 18 patients had diabetic maculopathy, and of these, 7 eyes of 6 patients revealed DME on OCT. When diabetic maculopathy was absent on fundus photographs, OCT could not reveal DME. Accordingly, 18 patients (20%) with diabetic maculopathy would have needed an additional examination with OCT in the sequential screening strategy, 6 (33%) of whom would have had DME on OCT. In an extended healthcare perspective analysis, the cost of the sequential screening strategy was higher than the cost of the combined screening strategy. There was a weak association between diabetic maculopathy on fundus photography and DME on OCT. The health economic analysis suggests that including OCT as a standard test in DR screening could potentially be cost-saving.


Asunto(s)
Retinopatía Diabética , Tamizaje Masivo , Tomografía de Coherencia Óptica , Humanos , Retinopatía Diabética/diagnóstico , Retinopatía Diabética/economía , Retinopatía Diabética/diagnóstico por imagen , Masculino , Femenino , Proyectos Piloto , Persona de Mediana Edad , Tomografía de Coherencia Óptica/economía , Tomografía de Coherencia Óptica/métodos , Estudios Transversales , Tamizaje Masivo/economía , Tamizaje Masivo/métodos , Anciano , Edema Macular/diagnóstico , Edema Macular/economía , Edema Macular/diagnóstico por imagen , Noruega/epidemiología , Adulto , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/economía , Análisis Costo-Beneficio
20.
Acta Ophthalmol ; 101(1): 100-108, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-35751448

RESUMEN

BACKGROUND/AIMS: To compare outcomes of acute endophthalmitis (EO) managed with either primary vitrectomy (PV) or primary intravitreal antibiotics (vancomycin and ceftazidime) followed by early vitrectomy (PIAEV) combined with polymerase chain reaction (PCR)-based diagnostics. METHODS: This was a prospective, comparative observational study of acute EO cases admitted to a regional vitreoretinal service over 18 months. Depending on whether immediate vitrectomy (within 6 h) was achievable, the EO cases were treated with either (1) PV or (2) PIAEV. Microbiology samples were collected either (A) before or (B) after administration of intravitreal antibiotics. The samples were analysed with broad-range 16S PCR and culture. RESULTS: The study included 41 EO cases. There were 19 post-injection EO, 18 post-cataract EO, three post-vitrectomy EO, and one blebitis-related EO. Fifteen of 19 PV cases and 15 of 21 PIAEV had a clinically meaningful improvement in best-corrected visual acuity (BCVA) of at least 15 letters at 3 months (p = 0.58). One patient was lost to follow-up. Twenty-three cases were culture- and PCR-positive, and seven additional cases were culture-negative but PCR-positive (p = 0.02). PCR increased the diagnostic yield for samples collected both before and after administration of intravitreal antibiotics. CONCLUSION: Primary vitrectomy or PIAEV allowed for vitrectomy for all cases of acute EO in a large region. Most eyes in both groups achieved a clinically meaningful improvement in BCVA. By combining culture with PCR in connection with the vitrectomy procedure, intravitreal antibiotics could be injected before microbiological sampling, thereby improving the door-to-treatment time without sacrificing microbial identification.


Asunto(s)
Endoftalmitis , Infecciones Bacterianas del Ojo , Humanos , Antibacterianos/uso terapéutico , Vitrectomía , Estudios Prospectivos , Infecciones Bacterianas del Ojo/diagnóstico , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Endoftalmitis/diagnóstico , Endoftalmitis/tratamiento farmacológico , Endoftalmitis/cirugía , Cuerpo Vítreo , Estudios Retrospectivos , Inyecciones Intravítreas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA